Programmdetails

Postervorträge

Moderne Therapiestrategien in der kardiovaskulären Medizin

Freitag, 5. April | 16:00 - 17:30 Uhr | Posterbereich 6

Vorsitz/Chair: Rüdiger Braun-Dullaeus (Magdeburg), Ilka Ott (Pforzheim)

Agenda

(P1623)
Intensive lipid – lowering therapy is highly cost effective in patients with ST – elevation myocardial infarction: a two – year follow – up of “Jena auf Ziel”
F. Härtel (Jena)
(P1624)
Determinanten der 6-Minuten Gehstrecke bei Patienten mit kardialer Transthyretin Amyloidose
C. Hosp (Würzburg)
(P1625)
Impact of discontinuing afterload-reducing medication on left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy
M. Abelmann (Hannover)
(P1626)
Calcimimetika verbessern direkt die durch Phosphat eingeschränkte Herzfunktion und Kardiomyozytenkontraktilität in Mäusen mit eingeschränkter Nierenfunktion
M. Leifheit-Nestler (Hannover)
(P1627)
Patient knowledge and management of major risk factors of HbA1c, blood pressure and LDL-C in coronary artery disease patients with and without diabetes mellitus: Results from the KNOW-ABC study
M. Brockmeyer (Düsseldorf)
(P1628)
Sirolimus vs Paclitaxel: Chronic vascular effects through DCB treatment in symptomatic peripheral artery disease
M. Sacirovic (Essen)
(P1629)
Comparison of LDL-C target achievement and Lp(a) assessment in patients with atherosclerotic cardiovascular disease in differing treatment specialties in Germany: Rationale and design of LipidSnapshot
W. Haerer (Ulm)
(P1630)
Interventional Outflow Graft Closure in Patients successfully weaned from LVAD
J. Jozwiak-Nozdrzykowska (Leipzig)
Diese Seite teilen